Knockdown studies in colorectal, glioblastoma, and gastric cancer models have shown that reducing POFUT1 expression significantly decreases cleaved NICD levels, leading to lower expressions of HES1 and HEY1 and reduced tumor cell proliferation and invasion [30, 32, 39]. This evidence concerns the gene HES1 and glioblastoma.